药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Delorazepam
Triptolide
The serum concentration of Triptolide can be decreased when it is combined with Omadacycline.
Delorazepam
Cloprostenol
The serum concentration of Cloprostenol can be decreased when it is combined with Omadacycline.
Delorazepam
Isosorbide
The serum concentration of Isosorbide can be decreased when it is combined with Omadacycline.
Delorazepam
Ulipristal
The serum concentration of Ulipristal can be decreased when it is combined with Omadacycline.
Delorazepam
Lonidamine
The serum concentration of Lonidamine can be decreased when it is combined with Omadacycline.
Delorazepam
Trestolone
The serum concentration of Trestolone can be decreased when it is combined with Omadacycline.
Delorazepam
Octylphenoxy polyethoxyethanol
The serum concentration of Octylphenoxy polyethoxyethanol can be decreased when it is combined with Omadacycline.
Delorazepam
p-Coumaric acid
The serum concentration of p-Coumaric acid can be decreased when it is combined with Omadacycline.
Delorazepam
Motretinide
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Motretinide is combined with Omadacycline.
Delorazepam
Zuretinol acetate
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Zuretinol acetate is combined with Omadacycline.
Delorazepam
Ro 12-7310
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Ro 12-7310 is combined with Omadacycline.
Delorazepam
Fenretinide
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Fenretinide is combined with Omadacycline.
Delorazepam
4-Oxoretinol
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when 4-Oxoretinol is combined with Omadacycline.
Delorazepam
Acetyldigoxin
Omadacycline can cause an increase in the absorption of Acetyldigoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Delorazepam
Metildigoxin
Omadacycline can cause an increase in the absorption of Metildigoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Delorazepam
L-tartaric acid
The therapeutic efficacy of Omadacycline can be decreased when used in combination with L-tartaric acid.
Delorazepam
Potassium citrate
The therapeutic efficacy of Omadacycline can be decreased when used in combination with Potassium citrate.
Delorazepam
(S)-Warfarin
The risk or severity of bleeding can be increased when Omadacycline is combined with (S)-Warfarin.
Delorazepam
Tioclomarol
The risk or severity of bleeding can be increased when Omadacycline is combined with Tioclomarol.
Delorazepam
Diphenadione
The risk or severity of bleeding can be increased when Omadacycline is combined with Diphenadione.